The Serotonin-Immune Axis in Preeclampsia
- 1 July 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Current Hypertension Reports
- Vol. 23 (7), 1-10
- https://doi.org/10.1007/s11906-021-01155-4
Abstract
Purpose of Review To review the literature and detail the potential immune mechanisms by which hyperserotonemia may drive pro-inflammation in preeclampsia and to provide insights into potential avenues for therapeutic discovery. Recent Findings Preeclampsia is a severe hypertensive complication of pregnancy associated with significant maternal and fetal risk. Though it lacks any effective treatment aside from delivery of the fetus and placenta, recent work suggests that targeting serotonin systems may be one effective therapeutic avenue. Serotonin dysregulation underlies multiple domains of physiologic dysfunction in preeclampsia, including vascular hyporeactivity and excess platelet aggregation. Broadly, serotonin is increased across maternal and placental domains, driven by decreased catabolism and increased availability of tryptophan precursor. Pro-inflammation, another hallmark of the disease, may drive hyperserotonemia in preeclampsia. Interactions between immunologic dysfunction and hyperserotonemia in preeclampsia depend on multiple mechanisms, which we discuss in the present review. These include altered immune cell, kynurenine pathway metabolism, and aberrant cytokine production mechanisms, which we detail. Future work may leverage animal and in vitro models to reveal serotonin targets in the context of preeclampsia’s immune biology, and ultimately to mitigate vascular and platelet dysfunction in the disease. Summary Hyperserotonemia in preeclampsia drives pro-inflammation via metabolic, immune cell, and cytokine-based mechanisms. These immune mechanisms may be targeted to treat vascular and platelet endophenotypes in preeclampsia.Keywords
Funding Information
- National Institutes of Health (5T32HL007121, R01HD089940, 1P50HD103556, 3UL1TR002537)
- American Heart Association (18SCG34350001, 19IPL134760288)
This publication has 102 references indexed in Scilit:
- Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depressionJCI Insight, 2012
- Placental drug transporters and their role in fetal protectionPlacenta, 2012
- Reduced placental vascular reactivity to 5-hydroxytryptamine in pre-eclampsia and the status of 5HT2A receptorsVascular Pharmacology, 2011
- Fetal, maternal, and placental sources of serotonin and new implications for developmental programming of the brainNeuroscience, 2011
- A transient placental source of serotonin for the fetal forebrainNature, 2011
- Serotonin Activates Dendritic Cell Function in the Context of Gut InflammationThe American Journal of Pathology, 2011
- Kynurenine is an endothelium-derived relaxing factor produced during inflammationNature Medicine, 2010
- Maternal serotonin is crucial for murine embryonic developmentProceedings of the National Academy of Sciences of the United States of America, 2007
- Serotonin Metabolism in the Fetus in Preeclampsia†Asia-Oceania Journal of Obstetrics and Gynaecology, 1994
- Serotonin and the Vascular SystemDrugs, 1986